-- Apollo, BP, Fabrinet, MannKind, Moody's, Oracle, RIM: U.S. Equity Movers
-- Lu Wang
-- 2010-06-25T20:13:17Z
-- http://www.bloomberg.com/news/2010-06-24/finish-line-h-r-block-oracle-research-in-motion-u-s-equity-preview.html

          
          
             Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in New York.  
 Banks gained after congressional negotiators today approved
the most sweeping overhaul of U.S. financial regulation since
the Great Depression, reshaping oversight of Wall Street and
some of its most complex financial products. Companies including
 JPMorgan Chase & Co.  (JPM US) and  Citigroup Inc.  (C US) will be
permitted to maintain swaps operations used to hedge risk under
the accord announced today.  
 JPMorgan advanced 3.9 percent to $39.52 for the biggest
gain in the Dow Jones Industrial Average. Citigroup rose 4
percent to $3.93.  Morgan Stanley  (MS US) added 3.1 percent to
$25.02.  Bank of America  Corp. (BAC US) gained 3.1 percent to
$15.48.  
 Moody’s Corp.  (MCO US), a credit-rating company, jumped the
most in the Standard & Poor’s 500 Index, rising 7 percent to
$22.04. Lawmakers agreed to modify legislation that would have
made it easier to sue credit-rating companies.  
 For-profit colleges fell after William Blair & Co. said
ongoing scrutiny may continue to weigh on the shares in coming
months. Yesterday’s Senate oversight hearing on the industry
“did little to persuade us that the regulatory focus on the
sector will lessen in the near term,” analyst  Brandon Dobell 
wrote in a note.  
 Apollo Group Inc.  (APOL US) declined 4.8 percent to $43.75
for the biggest loss in the S&P 500.  DeVry Inc.  (DV US) slipped
2.2 percent to $55.33.  Career Education Corp.  (CECO US) dropped
3.9 percent to $24.71.  ITT Educational Services Inc.  (ESI US)
decreased 3.5 percent to $87.12.  Corinthian Colleges Inc.  (COCO
US) sank 5.4 percent to $10.25.  
 Accenture Plc  (ACN US) rose 8.8 percent, the most since
October 2008, to $40.84. The second-largest technology-
consulting company reported fiscal third-quarter profit that
topped analysts’ estimates as demand for consulting projects
rebounded.  
 AeroVironment Inc.  (AVAV US) fell 7.9 percent to $21.43,
the lowest price since March 2009. The maker of low-flying
drones for U.S. military forces was notified in February of a
U.S. Justice Department investigation into its billing
practices, according to a regulatory filing.  
 ATP Oil & Gas Corp/United States  (ATPG US) rallied 12
percent, the most since March 12, to $12.22. The petroleum and
gas producer in the Gulf of Mexico obtained a $150 million term
loan paying 11 percent interest and replaced a $100 million bank
line deployed three months ago, according to a regulatory
filing.  
 BP Plc  (BP US) dropped 6 percent to $27.02, the lowest
price since June 1996. The London-based operator of the leaking
well in the Gulf of Mexico slumped on concern that the first
tropical storm of the Atlantic hurricane season may hamper
efforts to halt the leak.  
 Fabrinet  (FN US) rose 7.5 percent to $10.75 on the first
day of trading. The maker of optical telecommunications
equipment raised $85 million after reducing its initial public
offering price by as much as 29 percent.  
 FuelCell Energy Inc.  (FCEL US) dropped 17 percent to $1.25,
the lowest price since at least July 1992. The maker of
pollution-free power plants priced 24 million shares at $1.25
each, raising money to expand capacity.  
 KB Home  (KBH US) fell the most in the Russell 1000 Index,
erasing 9 percent to $11.12. The Los Angeles-based builder
specializing in homes for first-time buyers had a second-quarter
loss of 40 cents a share. Analysts surveyed by Bloomberg had
estimated a loss of 31 cents on average.  
 MannKind Corp.  (MNKD US) added 8.4 percent to $7.11, the
highest price since May 4. Diabetes patients who inhaled the
Valencia, California-based company’s insulin before meals and
took a shot of Sanofi-Aventis’s Lantus before bed controlled
blood sugar almost as well as those who got two injections,
MannKind-funded researchers said yesterday in the Lancet.  
 Molecular Insight Pharmaceuticals Inc.  (MIPI US) fell 19
percent, the most since March 2009, to $1.70. The
biopharmaceutical company said it failed to meet the Nasdaq
Stock Market listing requirement because it traded below the
minimum market value of $50 million for 30 consecutive days.  
 Research In Motion Ltd.  (RIMM US) declined 11 percent to
$52.23, the lowest price since April 2009. The maker of the
BlackBerry smartphone reported first-quarter sales of $4.24
billion, missing analysts’ estimates $4.35 billion amid
competition from Apple Inc.’s iPhone.  
 Synutra International Inc . (SYUT US) fell 13 percent, the
most since June 2009, to $18.20. The Chinese maker of infant
formula priced 3.3 million shares at $19 each, saying it plans
to use the money to repay debt.  
 Tibco Software Inc.  (TIBX US) surged 11 percent to $12.56,
the highest price since January 2005. The software company
posted second-quarter profit excluding some items of 15 cents a
share, exceeding the average analyst estimate by 18 percent.  
 To contact the reporter on this story:
 Lu Wang  in New York at   lwang8@bloomberg.net   
          
          


  


        